E-LIB Suche - Ergebnisse für: Arance, A.

1

Operational classification of cutaneous squamous cell carci..:

Gaudy‐Marqueste, C. ; Grob, J. J. ; Garbe, C....
Journal of the European Academy of Dermatology and Venereology. , 2024

Link: https://doi.org/10.1111/..

2

PO-1557 RT after Encorafenib and Binimetinib on BRAF mutate..:

Alvarez, A. ; Valduvieco, I. ; Arance, A....
Radiotherapy and Oncology. 182 (2023) - p. S1264 , 2023

Link: https://doi.org/10.1016/..

3

Corrigendum to 'Pembrolizumab for locally advanced and recu..:

Hughes, B.G.M. ; Munoz-Couselo, E. ; Mortier, L....
Annals of Oncology. 33 (2022) 8 - p. 853 , 2022

Link: https://doi.org/10.1016/..

4

Pembrolizumab for locally advanced and recurrent/metastatic..:

Hughes, B.G.M. ; Munoz-Couselo, E. ; Mortier, L....
Annals of Oncology. 32 (2021) 10 - p. 1276-1285 , 2021

Link: https://doi.org/10.1016/..

5

SEOM clinical guideline for the management of immune-relate..:

Majem, M. ; García-Martínez, E. ; Martinez, M....
Clinical and Translational Oncology. 22 (2020) 2 - p. 213-222 , 2020

Link: https://doi.org/10.1007/..

6

PCN40 Healthcare Resource Utilization in Patients Treated w..:

Mandala, M. ; Arance, A. ; Dummer, R....
Value in Health. 23 (2020) - p. S428 , 2020

Link: https://doi.org/10.1016/..

7

A retrospective chart review study describing metastatic me..:

Márquez-Rodas, I. ; Arance, A. ; Berrocal, A....
Clinical and Translational Oncology. 21 (2019) 12 - p. 1754-1762 , 2019

Link: https://doi.org/10.1007/..

8

Nivolumab (NIVO) versus ipilimumab (IPI) dans le traitement..:

Grob, J.-J. ; Weber, J. ; Del Vecchio, M....
Annales de Dermatologie et de Vénéréologie. 146 (2019) 12 - p. A102-A103 , 2019

Link: https://doi.org/10.1016/..

9

Dabrafenib plus trametinib versus dabrafenib monotherapy in..:

Long, G.V. ; Flaherty, K.T. ; Stroyakovskiy, D....
Annals of Oncology. 30 (2019) 11 - p. 1848 , 2019

Link: https://doi.org/10.1093/..

10

Données de survie globale de l'étude COLUMBUS, étude de pha..:

Robert, C. ; Dummer, R. ; Ascierto, P.A....
Annales de Dermatologie et de Vénéréologie. 145 (2018) 12 - p. S104-S105 , 2018

Link: https://doi.org/10.1016/..

11

Antitumor activity of ipilimumab after pembrolizumab in pat..:

Long, G.V. ; Robert, C. ; Arance, A....
European Journal of Cancer. 72 (2017) - p. S128-S129 , 2017

Link: https://doi.org/10.1016/..

12

Pembrolizumab for advanced melanoma: experience from the Sp..:

Spanish Melanoma Group ; González-Cao, M. ; Arance, A....
Clinical and Translational Oncology. 19 (2017) 6 - p. 761-768 , 2017

Link: https://doi.org/10.1007/..

13

Burden of Healthcare Costs for Merkel Cell Carcinoma Manage..:

Fonfria, H ; Llombart, B ; Arance, A...
Value in Health. 20 (2017) 9 - p. A427 , 2017

Link: https://doi.org/10.1016/..

14

Efficacy of pembrolizumab in patients with advanced mucosal..:

Butler, M. ; Hamid, O. ; Ribas, A....
European Journal of Cancer. 72 (2017) - p. S123 , 2017

Link: https://doi.org/10.1016/..

15

Efficacy and safety of nilotinib in patients with KIT-mutat..:

Guo, J. ; Carvajal, R.D. ; Dummer, R....
Annals of Oncology. 28 (2017) 6 - p. 1380-1387 , 2017

Link: https://doi.org/10.1093/..